184 related articles for article (PubMed ID: 6776980)
21. Serological and immunological characteristics of maternal anti-Rh(D) antibodies in predicting the severity of haemolytic disease of the newborn.
Zupańska B; Brojer E; Richards Y; Lenkiewicz B; Seyfried H; Howell P
Vox Sang; 1989; 56(4):247-53. PubMed ID: 2503936
[TBL] [Abstract][Full Text] [Related]
22. A case of hemolytic disease of the newborn caused by anti-M: serological study of maternal blood.
Matsumoto H; Tamaki Y; Sato S; Shibata K
Acta Obstet Gynaecol Jpn; 1981 Apr; 33(4):525-8. PubMed ID: 7195138
[TBL] [Abstract][Full Text] [Related]
23. [Anti-M antibodies in the pathogenesis of hemolytic disease of the newborn].
Lenkiewicz B; Kuśnierz-Alejska G; Lukowska J; Klimaszewska A
Acta Haematol Pol; 1989; 20(2):229-34. PubMed ID: 2638542
[TBL] [Abstract][Full Text] [Related]
24. Presence of anti-C but no anti-D in a cde/cde mother giving birth to a CDe/cde baby.
HEISTO H; KORNSTAD L
Vox Sang; 1961 May; 6():298-303. PubMed ID: 13713025
[No Abstract] [Full Text] [Related]
25. Anti-Diego a red blood cell alloantibody as a possible cause of anemia in a 3-week-old infant.
Hundric-Haspl Z; Balen-Marunic S; Tomasic-Susanj E; Tomicic M; Vujaklija-Stipanovic K
Arch Med Res; 2003; 34(2):149-51. PubMed ID: 12700013
[TBL] [Abstract][Full Text] [Related]
26. Radioimmunoassay evaluation of anti-C3d reactivity in broad spectrum commercial antiglobulin reagents.
Chaplin H; Hoffmann NL
Transfusion; 1982; 22(1):6-11. PubMed ID: 6977899
[TBL] [Abstract][Full Text] [Related]
27. IgG subclasses in rhesus-D immunization. Effects of weekly small volume plasmapheresis.
van't Veer-Korthof ET; Niterink JS; van Nieuwkoop JA; Eernisse JG
Vox Sang; 1981; 41(4):207-11. PubMed ID: 6801857
[TBL] [Abstract][Full Text] [Related]
28. Controlled trial of various anti-D dosages in suppression of Rh sensitization following pregnancy. Report to the Medical Research Council by the working party on the use of anti-D-immunoglobulin for the prevention of isoimmunization of Rh-negative women during pregnancy.
Br Med J; 1974 Apr; 2(5910):75-80. PubMed ID: 4207590
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms of anti-D action in the prevention of hemolytic disease of the fetus and newborn.
Brinc D; Lazarus AH
Hematology Am Soc Hematol Educ Program; 2009; ():185-91. PubMed ID: 20008198
[TBL] [Abstract][Full Text] [Related]
30. Haemolytic disease of the newborn due to anti-M.
Duguid JK; Bromilow IM; Entwistle GD; Wilkinson R
Vox Sang; 1995; 68(3):195-6. PubMed ID: 7625079
[TBL] [Abstract][Full Text] [Related]
31. Haemolytic disease of the newborn due to Rhesus anti-e antibody.
Chapman J; Waters AH
Vox Sang; 1981; 41(1):45-7. PubMed ID: 6798758
[TBL] [Abstract][Full Text] [Related]
32. Serologic comparison of a monoclonal anti-C3d with commercial antiglobulin reagents.
Barker JM
Transfusion; 1982; 22(6):507-10. PubMed ID: 6983162
[TBL] [Abstract][Full Text] [Related]
33. Direct quantitation of IgG subclasses 1, 2, and 3 bound to red cells by Rh1 (D) antibodies.
Shaw DR; Conley ME; Knox FJ; Khazaeli MB; LoBuglio AF
Transfusion; 1988; 28(2):127-31. PubMed ID: 3127969
[TBL] [Abstract][Full Text] [Related]
34. Blocked D phenomenon, a rare condition with Rh D haemolytic disease of newborn - a case report.
Sulochana PV; Rajesh A; Mathai J; Sathyabhama S
Int J Lab Hematol; 2008 Jun; 30(3):244-7. PubMed ID: 18205842
[TBL] [Abstract][Full Text] [Related]
35. Freezing red blood cells prepared for quality control of antiglobulin sera.
Szymanski IO; Harper JM; Odgren PR; Valeri CR
Transfusion; 1981; 21(5):498-501. PubMed ID: 6794193
[TBL] [Abstract][Full Text] [Related]
36. Haemolytic disease of the newborn due to anti-G.
Hadley AG; Poole GD; Poole J; Anderson NA; Robson M
Vox Sang; 1996; 71(2):108-12. PubMed ID: 8873421
[TBL] [Abstract][Full Text] [Related]
37. On the mechanism of tolerance to the Rh D antigen mediated by passive anti-D (Rh D prophylaxis).
Kumpel BM
Immunol Lett; 2002 Jun; 82(1-2):67-73. PubMed ID: 12008036
[TBL] [Abstract][Full Text] [Related]
38. Quantitation of C3 subcomponents on red cells coated with complement in vitro.
Freedman J; Massey A
J Clin Pathol; 1980 Oct; 33(10):977-83. PubMed ID: 7430364
[TBL] [Abstract][Full Text] [Related]
39. Rh blood group-specific antibodies in immune hemolytic anemia induced by nomifensine.
Salama A; Mueller-Eckhardt C
Blood; 1986 Dec; 68(6):1285-8. PubMed ID: 3096400
[TBL] [Abstract][Full Text] [Related]
40. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
Altuntas N; Yenicesu I; Himmetoglu O; Kulali F; Kazanci E; Unal S; Aktas S; Hirfanoglu I; Onal E; Turkyilmaz C; Ergenekon E; Koc E; Atalay Y
Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
